Ask a clinical question and tap into Healio AI's knowledge base. Read more Ozurdex is a biodegradable dexamethasone implant placed into the vitreous cavity in cases that are predisposed to development of macular edema due to retinal vein occlusion, noninfectious uveitis or diabetes. The implant, from AbbVie, gradually releases 0.7 mg dexamethasone into the intravitreal cavity and eventually degrades into glycolic and lactic acid.
Ashvin Agarwal
Southern Asia
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Ashvin
Contact Ashvin, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack